Literature DB >> 21596683

On a different level: telavancin versus vancomycin for hospital-acquired pneumonia.

Giorgio Tarchini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596683     DOI: 10.1093/cid/cir189

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

Review 1.  Systematic Review and Meta-Analysis of the Efficacy and Safety of Telavancin for Treatment of Infectious Disease: Are We Clearer?

Authors:  Junlan Chuan; Yuan Zhang; Xia He; Yuxuan Zhu; Lei Zhong; Dongke Yu; Hongtao Xiao
Journal:  Front Pharmacol       Date:  2016-09-23       Impact factor: 5.810

Review 2.  Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis.

Authors:  Konstantinos A Polyzos; Michael N Mavros; Konstantinos Z Vardakas; Marinos C Makris; Petros I Rafailidis; Matthew E Falagas
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.